Angelike Kefalas, MBA

Chief Marketing and Business Officer 


Angelike Kefalas has more than 20 years of experience in the diagnostic, medical device and pharmaceutical industry. She has a rich background in commercializing FDA-approved 510(k) products and selling to healthcare professionals, hospitals, physicians, patients/consumers and payers.  In addition, she has built high performing commercial launch teams from the ground-up at several start-ups.   

Before Pinpoint, Angelike was Head of Global Marketing and Communications at Medicines360,  successfully  launching LILETTA®, a 510(k) FDA and EMA-approved pharmaceutical drug-device product, with Mediciness360's co-promote partner Allergan. Before that, she was Vice President of Marketing at Amplify Health and Executive Director, Commercial at Tethys Bioscience, a molecular diagnostic company that commercialized and sold PreDx®, a 7 biomarker CLIA approved blood test.  She also was the Director of Strategic Marketing, Market Research and Analytics at Abbott Diagnostics, relaunching the FreeStyle Glucose Meter, a POC consumer-driven med-device. 

Throughout her career, Angelike has been involved in 7 product launches, 4 of which have been global.  Angelike’s areas of expertise include: product and company positioning, developing go-to-market commercial strategy, optimizing sales growth, and business development.   

Angelike holds an MBA from Columbia Business School, Columbia University, NY and a Masters degree from Haas Business School, University of California Berkeley (through a joint degree program). She also received her B.S. from Brandeis University in Molecular Biology.   ​